Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Evaluation of a Precision Prevention Strategy for Early Female Fertility Decline Based on OvaRePred-Plus: A Multicenter Cluster Randomized Controlled Trial

NCT07581444 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT07581444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07581444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Evaluation of a Precision Prevention Strategy for Early Female Fertility Decline Based on OvaRePred-Plus: A Multicenter Cluster Randomized Controlled Trial
Lead sponsor
Peking University Third Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 30, 2026
Completion date
December 31, 2026
Enrollment
384 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diminished ovarian reserve, female fertility decline, infertility prevention, reproductive health